The Alzheimer's Disease Neuroimaging Initiative (ADNI) has continued development and standardization of methodologies for biomarkers and has provided an increased depth and breadth of data available to qualified researchers. This review summarizes the over 400 publications using ADNI data during 2014 and 2015. Taken together, these studies fundamentally deepen the understanding of AD progression and its underlying genetic basis, which in turn informs and improves clinical trial design.
Downloads
Similar Publications
- DNA Contamination, Degradation, Damage and Associated Microbiomes: A Comparative Analysis through Massive Parallel Sequencing and Electrophoresis
- The Role of Social-Emotional Factors in Bystanders' Judgments and Responses to Peer Aggression and Following Retaliation in Adolescence
- Crack as Proxy: Aggressive Federal Drug Prosecutions and the Production of Black-White Racial Inequality